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inTRODUCTiOn
Chronic periodontitis is a multifactorial disease characterized by the presence of dysbiotic 
microbial communities that, together with genetic and environmental factors, results in chronic 
inflammation of the periodontium, which ultimately may trigger alveolar bone resorption (1). The 
reported associations between periodontal disease and other chronic disorders, including meta-
bolic, cardiovascular, respiratory, and arthritic diseases (2), reinforce the importance of elucidating 
the cell types and molecular mechanisms involved. Chronic inflammation of gingival tissue has 
long been associated with infiltration of the gingiva by activated T and B cells and secretion of 
inflammatory cytokines and immunoglobulins. However, the role of T cells in periodontal disease 
is controversial with reports showing that they have both protective and destructive roles (3, 4). 
Moreover, while most studies have focused on CD4+ T cells and B cells, the role played by gingival 
CD8+ T cells has been overlooked. On the basis of data published recently, we discuss the possibility 
that gingival CD8+ T cells contain a pool of cells with regulatory/suppressor properties involved in 
the maintenance of gingival tissue integrity by constitutively downregulating inflammation under 
homeostatic conditions and initiating repairing mechanisms in case of tissue injury. These basic 
physiological roles could be surpassed and hidden when a potent and/or chronic immune response 
against pathogenic bacterial colonization occurs, thus leading to bone loss. Elucidation of the 
basic physiological roles of particular CD8+ T cells present in periodontal tissue and the rules they 
follow in order to cope with minor versus major disruption of tissue homeostasis can improve our 
understanding of how they react to changes in their environment and ultimately allow the develop-
ment of novel therapeutic approaches to favor anti-inflammatory responses and bone repair.
THE ROLES OF CD8+ T CELLS: CYTOTOXiCiTY, 
SUppRESSiOn, AnD TiSSUE REpAiR
One fascinating aspect of CD8+ T cells is their heterogeneity, as they differ in terms of T cell 
receptor (TCR) diversity and antigen specificity, which allows them to monitor for shifts in 
peptide antigens presented in MHC class I molecules expressed on the plasma membrane of 
all nucleated cells. CD8+ T cells acquire functional properties after being activated, normally in 
secondary lymphoid organs, by antigen presenting cells (APC). As a result, some acquire innate 
receptors, including NK receptors, enlarging the kind of stimuli they can receive (5). In addition 
to the well-documented cytotoxic activities, CD8+ T cells might also have regulatory/suppres-
sor functions (thereafter CD8+ Treg) since they have the ability to control other leukocytes to 
avoid excessive immune activation and its pathological consequences (6, 7). Although in humans 
many phenotypes have been described for CD8+ Treg, the most reliable maker is the transcrip-
tion factor Foxp3 (7). Nevertheless, CD8+ Tregs have also been described as Foxp3low (8) and 
Foxp3−, including CD8lowCD28−, CD8+CD103+, and non-antigen-specific CD8+CD28− (9–11). 
CD8+ Tregs are also diverse regarding the mechanisms of suppression, which include induction 
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of tolerogenic APC, withdrawal of homeostatic cytokines, 
secretion of anti-inflammatory cytokines, and cell cytotoxicity 
(6, 7). The importance of CD8+ Treg in the context of tissue 
inflammation is illustrated by a series of studies showing that 
interactions between intestinal epithelial cells and CD8+ T cells 
induce a population of CD8+CD28−CD103+ T cells endowed 
with suppressor functions (12, 13). Subsequent studies by the 
same group demonstrated that the disruption of their suppres-
sor activities is associated with mucosal inflammation (8). The 
regulatory functions of highly differentiated CD8+ T cells might 
also include tissue repair (14), although it has been mainly 
described in CD4+ Treg for lung (15), and αβ and γδ T cells 
for bone (16, 17). Indeed, the experimental evidence for the 
existence of CD8+ T cells endowed with tissue repair and/or 
bone regeneration properties within the gingival tissue is very 
scarce as described below, which warrants further studies.
CD8+ T CELLS AnD BOnE HOMEOSTASiS: 
CYTOKinES MATTER
An early seminal study using NOD/SCID mice transplanted 
with human peripheral blood lymphocytes as a model of peri-
odontitis showed that human CD4+ T cells in the periodontium 
triggered local alveolar bone destruction by secreting osteo-
protegerin ligand, also known as RANKL (18). Subsequently, 
it was demonstrated that several pro-inflammatory cytokines, 
for example TNF-α, ultimately converge on the expression of 
RANKL thus promoting osteoclastogenesis (19). In contrast, 
anti-inflammatory cytokines secreted by CD8+ T cell with 
an effector–memory phenotype, such as IL-10 and TGF-β  
(7, 20), have been shown to be bone protective in in  vivo and 
in vitro models of bone regeneration (19, 21, 22). The role of pro-
inflammatory cytokines IL-17 and IFN-γ in bone homeostasis 
remains controversial. IL-17 is mainly produced by CD4+ Th17 
cells and γδ T cells and has been associated with bone destruc-
tion (23). However, recent experimental studies in knockout mice 
models have shown that IL-17 may participate in the early phases 
of bone regeneration by directly stimulating osteoblastogenesis 
(16, 17). Regarding IFN-γ, it has been shown to promote as well 
as to inhibit bone formation (23–25). The contrasting effects of 
IFN-γ could perhaps be explained by the fact that it may exert a 
direct inhibitory effect on osteoclastogenesis by interfering with 
the RANK pathway, and at the same time promote bone destruc-
tion indirectly by inducing antigen-presenting MHC molecules 
on APC, leading to increased production of TNF-α by activated T 
cells (26). Whether the IFN-γ discrepancies on bone homeostasis 
may result from the study of early versus late phases of bone 
formation, as it happens with IL-17, remain to be elucidated. 
Importantly, recent studies in models of bone regeneration have 
shown that mouse CD8+ T cells and in vitro expanded human 
CD8+ T cells secrete Wnt10b, a cytokine/factor that promotes 
osteoblastogenesis (27). Even though the exact mechanism used 
by CD8+ T cells to promote bone regeneration remains to be 
elucidated, the accumulated evidence from experimental models 
of bone regeneration suggests that cytokines and factors secreted 
by CD8+ T cells could be involved.
GinGiVAL CD8+ T CELLS AnD CHROniC 
pERiODOnTiTiS
The majority of studies on gingival tissue of chronic periodon-
titis focused on the functional characterization of CD4+ T cells 
and B cells and concluded that the presence of CD4+ Th1 cells 
and antibody-secreting B cells, as a result of the host immune 
response against bacterial infection, was associated with chronic 
inflammation and disease progression, namely alveolar bone 
loss (1). Indeed, a detrimental role of gingival CD4+ T cells 
in alveolar bone destruction under chronic periodontitis has 
been steadily proposed since the seminal work of Penninger’s 
group (18). These conclusions are supported by an in  vivo 
study in CD4- and CD8-deficient mice showing that CD4+ T 
cells contribute to the alveolar bone loss in mice (28). Although 
CD4+ Treg cells have been shown to confer protection in animal 
models of periodontal disease (29, 30), they are present in low 
numbers in gingival tissue of subjects with chronic periodontal 
disease (31, 32) and some of them may switch to an inflamma-
tory Th17 phenotype (33).
Although the role of CD8+ T cells in chronic periodontitis is 
less obvious, most studies have consistently shown that despite 
being more abundant in gingival tissues of periodontitis patients 
than in patients with gingivitis or healthy controls, CD8+ T cells 
are not involved in gingival tissue pathology (3, 4). Similar 
conclusions were drawn from mice studies (28). Interestingly, a 
recent comprehensive study using multiparametric flow cytom-
etry has revealed that T cells present in healthy gingival tissue 
are predominantly effector–memory, as determined by the use 
of CD45RA, CD45RO, and CCR7, with CD4+ and CD8+ T cells 
being more abundant than B cells (34). In gingival tissue from 
chronic periodontitis, a marked increase in total CD4+ T cells, 
CD8+ T cells, and B cells, akin to neutrophils, was observed, and 
most of the CD4+ T cells produced IL-17 (34). Although in the 
study of Dutzan et al. CD8+ Treg are not detected in the gingiva 
of chronic periodontitis patients (34), previous studies showed 
that some gingival CD8+ T cells lack CD28 while expressing the 
inhibitory receptor PD1 (35–37). These features are associated 
with an effector–memory phenotype (20). These data, together 
with early in vitro studies showing that CD8+ T cells confer bone 
protection by suppressing osteoclastogenesis (38, 39), suggest 
that effector–memory CD8+ T cells present in gingival tissue 
might play a key basic physiological role in safeguarding tissue 
integrity (Figure  1). Nevertheless, further studies are needed 
to ascribe a particular protective role to specific CD8+ T cells. 
Indeed, this role may be overwhelmed and masked by inflated 
T and B cell immune responses against bacterial aggression 
under dysbiotic bacterial growth, with dramatic outcomes for 
bone homeostasis.
GinGiVAL CD8+ T CELLS: MOLECULAR 
SiGnALS AnD EFFECTOR FUnCTiOnS
Given the effector–memory phenotype (34–37), and unlike 
CD4+ T cells that express CD28 and may respond to TCR/
CD28-mediated signals, gingival CD8+ T cells may preferentially 
FiGURE 1 | proposed simplified model for the role of gingival CD8+ 
T cell-derived cytokines and factors in alveolar bone homeostasis in 
health and chronic periodontitis. (A) Anatomy of soft and hard 
periodontal tissues showing selected cells: CD8+ T cells, herein collectively 
referred as memory CD8+ T cells or TM (blue), osteoblasts (green), and 
osteoclasts (purple), in healthy periodontal tissues (left panel) and in chronic 
periodontitis (right panel). Note accumulation of pathogenic bacteria on the 
tooth surface, formation of a pocket with gingival crevicular fluid (GCF) 
accumulation, gingival attachment loss, inflamed gingiva (reddish), as well as 
loss of alveolar bone in chronic periodontitis due to imbalance in the 
equilibrium between osteoblastogenesis and osteoclastogenesis toward the 
latter (right panel). (B) Bone-protective versus bone-destructive factors that 
can be produced by gingival CD8+ TM cells. Under homeostatic conditions 
(left panel), IL-10 and TGF-β secreted by CD8+ TM cells suppress 
osteoclastogenesis, while Wntb10 promotes differentiation of mesenchymal 
stem cells (MSC) into osteoblasts and inhibits their apoptosis. In addition, 
CD8+ TM cells secrete amphiregulin (AREG) that downplays gingival 
inflammation and promotes epithelial and stromal tissue repair (data not 
shown, see text). Overall, these bone promoting cytokines counteract the 
bone loss induced by commensal bacteria (see text). The role of IFN-γ and 
IL-17 under homeostatic conditions on osteoclastogenesis and 
osteoblastogenesis is uncertain (dashed lines). Under chronic periodontitis 
(right panel) high levels of TNF-α, and perhaps of IFN-γ and IL-17, produced 
in response to pathogenic bacterial colonization surpass the protective role 
of the aforementioned cytokines, promoting osteoclastogenesis and 
increasing apoptosis of osteoblasts, thus favoring bone loss.
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be activated in a TCR-independent manner by local signals 
produced during stress and/or injury, including a variety of 
endogenous products that signal through innate receptors, 
as discussed elsewhere (20). As a result, upon innate receptor 
triggering gingival CD8+ T cells may secrete cytokines, such as 
IL-10 and IFN-γ, reported to have bone repairing properties (23, 
26). Interestingly, a recent study showed that, unlike inflamma-
tory cytokines, the levels of IL-10 remained unchanged in the 
gingival crevicular fluid of chronic periodontitis patients after 
non-surgical periodontal therapy (40), suggesting that IL-10 
may have indeed a basic physiologic role in the healthy gingiva, 
as demonstrated in IL-10-deficient mice (41). In addition, 
gingival CD8+ T cells could further improve tissue healing after 
receiving environmental signals by secreting amphiregulin, an 
anti-inflammatory cytokine expressed by CD8+ T cells (42), 
which has been shown to promote tissue repair (14), and is 
upregulated in the gingival stroma in a mice model of chronic 
periodontitis (43) (Figure 1).
Evidence for the expression of innate/inhibitory receptors 
by gingival CD8+ T cells, including KIR, LIR, TLR, and oth-
ers, is very scarce, which warrants the need and importance 
of studying their expression. Thus, though initially considered 
a T cell exhaustion marker, the reported expression of PD1 
by gingival CD8+ T cells (37) could potentially be involved 
in limiting tissue damage through interaction with its ligand, 
which can be expressed by a variety of stromal cells (44, 45). On 
the other hand, in vitro studies in mice have recently proposed 
that CD8+ T cells could be activated by osteoclasts via antigen 
cross-presentation, resulting in the formation of CD8+ Treg that 
could inhibit bone resorption through secretion of IFN-γ (46). 
These results are challenging and suggest that bone-protective 
CD8+ T cells could be generated in loco from resident CD8+ T 
cells in the alveolar bone surface, while bone-protective CD4+ 
Treg may be recruited from circulation (29, 30). In this respect, 
it is important to mention that the commensal bacteria present 
in the gingiva may exert an important role in alveolar bone 
homeostasis. Thus, a series of animal studies performed in 
germ-free versus specific pathogen-free versus wild-type models 
have shown that commensal bacteria present in the gingiva is 
responsible for physiological alveolar bone loss (1, 47), suggest-
ing that gingival T cells and their secreted cytokines might be 
present from birth, as seen in other peripheral tissues (48), and 
contribute to physiologic alveolar bone homeostasis in healthy 
conditions.
COnCLUDinG REMARKS AnD FUTURE 
pROSpECTS
While scant, there is evidence that resident gingival CD8+ T cells 
may contain lymphocytes with regulatory functions, including 
suppression of bone-destructive cytokines and repair of alveolar 
bone, two activities that could be intertwined. However, the host 
immune response that takes place upon chronic bacterial coloni-
zation of the teeth and that results in the recruitment of innate and 
adaptive inflammatory cells (34) will likely disrupt these homeo-
static activities. Thus, it turns out of the foremost importance to 
elucidate the role of gingival effector–memory CD8+ T cells in 
bone remodeling in health and sickly conditions. To do that, the 
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use of mice models lacking selected populations (cytotoxic CD8+ 
T cells versus CD8+ Treg, etc.), suppressive cytokines or tissue-
specific chemokine receptors, or adoptive transfer of CD8+ Treg 
should provide insights into the bone-protective role of gingival 
CD8+ T cells (30, 49, 50). These studies will certainly broaden our 
understanding of the relationship of gingival CD8+ T cells with 
the periodontium and enable the development of novel therapies 
to inhibit bone loss under pathological conditions.
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